HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 289-300 of 1,811
Other study type icon
CompletedNCT03542643

Omega-3 Polyunsaturated Fatty Acids in Youth With ADHD

Official study title

A Double-blind Randomised Controlled Trial of N-3 PUFAs in Children With Attention Deficit Hyperactivity Disorder

This study has finished and is no longer accepting participants.

In Taichung
ADHDPlacebo comparisonAges 6–18
Countries
Taiwan
Sponsor
China Medical University Hospital
Drug study icon
CompletedNCT06185985

Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD and Mood Symptoms

Official study title

A Phase IV, Open-Label, Decentralized Clinical Trial to Evaluate the Efficacy and Safety of Qelbree® in Adults With Attention-Deficit/Hyperactivity Disorder and Mood Symptoms

This study has finished and is no longer accepting participants.

In New York
ADHDMedication studyAges 18+
Countries
United States
Sponsor
Supernus Pharmaceuticals, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT02160262

Safety Study in Adults With ADHD

What is this study about?

Researchers studied Dasotraline, tracking side effects to assess safety and tolerability in adults with ADHD.

This study has finished and is no longer accepting participants.

Multiple locations, including Beverly Hills
ADHDMedication studyAges 18–55
Countries
United States
Sponsor
Sumitomo Pharma America, Inc.
Drug study icon
CompletedNCT00418262

Safety study of long Term Tolerability and Safety of Atomoxetine in ADHD

Official study title

An Open-label Study of the Long Term Tolerability and Safety of Atomoxetine in Treating the Inattention, Impulsivity and Hyperactivity in Children With Fetal-Alcohol Syndrome or Effects.

This study has finished and is no longer accepting participants.

In Oklahoma City
ADHDMedication studyAges 4–11
Countries
United States
Sponsor
University of Oklahoma
Drug study icon
CompletedNCT00723190

Safety study of CLONICEL (Clonidine HCl Sustained Release) in ADHD

What is this study about?

This study evaluated the safety of CLONICEL (Clonidine HCl sustained release) for people with ADHD.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
ADHDMedication studyAges 6–17
Countries
United States
Sponsor
Shionogi
Drug study icon
CompletedNCT04081363

Single-dose study to Assess the Pharmacokinetics of Centanafadine Extended-release Capsules in Pediatric people with Attention-deficit Hyperactivity Disorder (ADHD)

Official study title

A Pilot Phase 2a, Multicenter, Open-label, Single-dose Trial to Assess the Pharmacokinetics of Centanafadine Extended-release Capsules After Oral Administration in Pediatric Subjects (9 to 12 Years, Inclusive) With Attention-deficit Hyperactivity Disorder

This study has finished and is no longer accepting participants.

In New York
ADHDMedication studyAges 9–12
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT03788902

OT and Social Cognition in Children With ADHD: Impact of MPH

Official study title

Oxytocin and Social Cognition in Children With Attention Deficit Hyperactivity Disorder: Impact of Methylphenidate

This study has finished and is no longer accepting participants.

Location not clearly listed
ADHDMedication studyAges 6–12
Countries
Sponsor
Shalvata Mental Health Center
Drug study icon
CompletedNCT03136263

Oxytocin and Cognitive Control in Adult ADHD

Official study title

Effects of Oxytocin on Cognitive Control in Adults With Attention Deficit/Hyperactivity Disorder

This study has finished and is no longer accepting participants.

In Boston
ADHDMedication studyAges 18–55
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.